
fentanyl citrate sublingual brand names and other generic formulations include:
No brand names available
chlorpheniramn-pyrilamn-phenyleph er oral brand names and other generic formulations include:
AllerTan Oral, Chlorex-A 12 Oral, Chlor-Tan A 12 Oral, Conal Oral, Decotan Oral, Equitan Oral, Equi-Tan Pediatric Oral, Gelhist Oral, Gelhist Pediatric Oral, Histatan Oral, Histatan Pediatric Oral, Mooretan Decongestant Oral, Nalex A 12 Oral, Pro-Tannate Pediatric Oral, Rhinatate Pediatric Oral, Ro-Tan Oral, R-Tannamine Oral, R-Tannamine Pediatric Oral, R-Tannate Oral, R-Tannate Pediatric Oral, Ryna-Mine Oral, Rynatan-S Oral, Rynatan-S Pediatric Oral, Rynatate Oral, TanaCof-A 12 Oral, Tanamine Oral, Tanamine Pediatric Oral, Tandral Oral, Tannate Oral, Tannate S Oral, Tanoral Oral, Tanoral Pediatric Oral, Tanoral-S Oral, Tanorin Oral, Tri Tann Pediatric Oral, Tri-Gestan S Oral, Tri-Hist Pediatric Oral, Triotann Oral, Triotann-S Oral, Triotann-S Pediatric Oral, Triple Tannate Pediatric Oral, Tritan Oral, Tri-Tanate Oral, Tritann Oral, Tri-Tannate Oral, Tri-Tannate Pediatric Oral, Tri-Tannate S Pediatric Oral, URL-Tannate Oral, URL-Tannate Pediatric Oral
fentanyl citrate sublingual and chlorpheniramn-pyrilamn-phenyleph er oral
fentanyl citrate sublingual , chlorpheniramn-pyrilamn-phenyleph er oral . Either increases toxicity of the other by added drug effects. Combining fentanyl with this drug may cause urinary retention and increase risk of constipation.
fentanyl citrate sublingual and chlorpheniramn-pyrilamn-phenyleph er oral
fentanyl citrate sublingual , chlorpheniramn-pyrilamn-phenyleph er oral . Either increases toxicity of the other by pharmacodynamic synergism. Coadministration of fentanyl with anticholinergics may increase risk for urinary retention and/or severe constipation, which may lead to paralytic ileus.
Check for more interactions with the Drug Interaction Checker
Drug Interaction Categories
Contraindicated
Never use this combination of drugs because of high risk for dangerous interaction
Serious
Potential for serious interaction; regular monitoring by your doctor required or alternate medication may be needed
Significant
Potential for significant interaction (monitoring by your doctor is likely required)
Minor
Interaction is unlikely, minor, or nonsignificant